| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/18/2005 | US20050178396 Polymer compositions and methods for their use |
| 08/18/2005 | US20050178395 Polymer compositions and methods for their use |
| 08/18/2005 | US20050178020 Lyophilization method and apparatus for producing particles |
| 08/18/2005 | DE3933164B4 Prepn. for iron supply - comprises specified amts. of specified iron contg. cpd., sodium carbonate or bi:carbonate and a neutralising agent |
| 08/18/2005 | DE102004005054A1 Microcapsule immobilizing species for use in chemistry, food- or pharmaceutical technologies is stable when stored in concentrated medium and is ruptured on slight stressing following dilution |
| 08/18/2005 | DE102004004122A1 Verfahren zur Phasenumwandlung in molekularen Festkörpern Method of phase transformation in molecular solids |
| 08/18/2005 | DE102004003801A1 Recovering melanin from plant materials, for use e.g. in cancer treatment or as semiconductor, by extracting with sodium hydroxide solution, acidifying extract and purifying precipitate |
| 08/18/2005 | DE102004001558A1 Arzneimittel zur topischen Applikation bei Tieren Drugs for topical application in animals |
| 08/18/2005 | CA2556181A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent |
| 08/18/2005 | CA2555033A1 Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof |
| 08/18/2005 | CA2554975A1 Methods of preventing and treating sars using low ph respiratory tract compositions |
| 08/18/2005 | CA2554927A1 Stable amorphous forms of montelukast sodium |
| 08/18/2005 | CA2554892A1 Flat system for using in the oral cavity |
| 08/18/2005 | CA2554649A1 Rapidly dissolving film for delivery of an active agent |
| 08/18/2005 | CA2554620A1 Pyrazoloacrydone derivative-containing solution |
| 08/18/2005 | CA2554262A1 Sustained-release preparations |
| 08/18/2005 | CA2554140A1 Methods and compositions for treating cancer |
| 08/18/2005 | CA2554030A1 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders |
| 08/18/2005 | CA2553658A1 Microemulsion formulations comprising particular substance p antagonists |
| 08/18/2005 | CA2553039A1 Antiparasitic composition |
| 08/18/2005 | CA2553038A1 Compositions substantially free of galactomannan containing piperacillin and tazobactam |
| 08/18/2005 | CA2552925A1 Semisolid matrix pharmaceutical formulations |
| 08/18/2005 | CA2552463A1 New compositions containing quinoline compounds |
| 08/18/2005 | CA2550848A1 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 08/18/2005 | CA2547843A1 Composition comprising polymeric material and uses thereof |
| 08/17/2005 | EP1564220A1 Sustained release drug carrier |
| 08/17/2005 | EP1563868A1 Treatment kit comprising a composite structure and an excitation head |
| 08/17/2005 | EP1563850A2 Method of increasing the bioavailability and tissue penetration of azithromycin |
| 08/17/2005 | EP1563846A1 Endogenous repair factor production promoters |
| 08/17/2005 | EP1563844A2 Wound healing formulations containing human plasma fibronectin |
| 08/17/2005 | EP1563837A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent |
| 08/17/2005 | EP1563835A1 Hydroxypropylmethylcellulose capsule preparation having teprenone encapsulated therein |
| 08/17/2005 | EP1563834A1 Hollow nanoparticles of protein and drug using the same |
| 08/17/2005 | EP1563833A1 Pharmaceutical compositions with amorphous tibolone. |
| 08/17/2005 | EP1563832A1 Liposome comprising a compound containing 2 polyalkylene glycol groups |
| 08/17/2005 | EP1562963A1 Novel lipophilic compounds and uses thereof |
| 08/17/2005 | EP1562633A1 Pharmaceutical product for endonasal administration for treating central nervous system diseases and disorders |
| 08/17/2005 | EP1562630A2 Injectible bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 08/17/2005 | EP1562626A2 Stabilized, solid-state polypeptide particles |
| 08/17/2005 | EP1562607A1 Pharmaceutical dosage forms of biguanide-sulfonylurea combinations |
| 08/17/2005 | EP1562602A2 Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness |
| 08/17/2005 | EP1562585A1 Daily melatonin dosing units |
| 08/17/2005 | EP1562573A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 08/17/2005 | EP1562572A2 Pharmaceutical solutions of modafinil compounds |
| 08/17/2005 | EP1562568A1 Treatment of heaves |
| 08/17/2005 | EP1562561A1 Stable aerosol formulation of peptides and proteins with non-cfc propellants |
| 08/17/2005 | EP1562560A1 Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| 08/17/2005 | EP1562559A2 Bio-degradable colloid particles, in particular for pulmonary applications |
| 08/17/2005 | EP1562558A1 Palatable micro-capsules |
| 08/17/2005 | EP1562557A2 Geodate delivery vehicles |
| 08/17/2005 | EP1562556A2 Pharmaceutical compositions and dosage forms of thalidomide |
| 08/17/2005 | EP1562555A2 Sustained release l-arginine formulations and methods of manufacture and use |
| 08/17/2005 | EP1562554A1 A method for normalizing insulin levels |
| 08/17/2005 | EP1562553A2 Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |
| 08/17/2005 | EP1562552A1 Controlled release carvedilol compositions |
| 08/17/2005 | EP1562551A1 Media milling using nonspherical grinding media |
| 08/17/2005 | EP1562549A1 Palatable carrier for medicine for an animal |
| 08/17/2005 | EP1562548A1 Oral testosterone delivery system with improved sustained release |
| 08/17/2005 | EP1562546A1 Depot formulations of arylheterocyclic active agents in the form of a suspension |
| 08/17/2005 | EP1562543A1 Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil |
| 08/17/2005 | EP1562535A2 Dosage forms containing stabilized choline and method for preparing same |
| 08/17/2005 | EP1562531A2 Topical skin care composition |
| 08/17/2005 | EP1519979A4 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1411895B1 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 08/17/2005 | EP1326609B1 Stable oral formulation containing benzimidazole derivative |
| 08/17/2005 | EP1319397B1 Suppositories sustained in the lower rectum |
| 08/17/2005 | EP1294372B1 Dry powder formulation comprising racecadotril |
| 08/17/2005 | EP1282663B1 Gel comprised of a poly-a-1,4-glucan and starch |
| 08/17/2005 | EP1173367B1 Medicament carrier |
| 08/17/2005 | EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 08/17/2005 | EP1150682B1 UBIQUINONE Qn FOR THE TREATMENT OF MIGRAINE PAINS |
| 08/17/2005 | EP1137344B1 Preparation of cholesterol reducing edible products by mixing plant sterols/stanols in a melt of a food emulsifier |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP1011646B1 Pharmaceutical compositions and devices for their administration |
| 08/17/2005 | EP1003478B1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 08/17/2005 | EP0972520B1 Freeze-dried composition of bone morphogenetic protein human mp52 |
| 08/17/2005 | CN2717439Y Chinese herbal medicine set tablets for external application |
| 08/17/2005 | CN2717438Y Double-layer coating biological active-micro capsule for nutrients |
| 08/17/2005 | CN2717437Y Percutaneous administration nano-spectrum medicine plaster |
| 08/17/2005 | CN1656205A Stabilization of granules |
| 08/17/2005 | CN1656178A Oil-soluble pigment compositions |
| 08/17/2005 | CN1655847A Self-administered contraceptive injection of oily solution |
| 08/17/2005 | CN1655841A Device and method for delivering or withdrawing a substance through the skin |
| 08/17/2005 | CN1655826A Non-viral gene delivery system |
| 08/17/2005 | CN1655824A Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same |
| 08/17/2005 | CN1655823A Topically applicable pharmaceutical preparation |
| 08/17/2005 | CN1655811A 组合物及其治疗用途 The composition and therapeutic use |
| 08/17/2005 | CN1655808A Compositions for treating and/or preventing pollinosis |
| 08/17/2005 | CN1655805A Chewable compositions containing a gel-forming extract of psyllium |
| 08/17/2005 | CN1655802A Bioadhesive directed somatic cell therapy |
| 08/17/2005 | CN1655795A Progestagenic dosage units |
| 08/17/2005 | CN1655794A Norethindrone sustained release formulations and methods associated therewith |
| 08/17/2005 | CN1655790A Medicinal composition |
| 08/17/2005 | CN1655789A New pharmaceutical compositions containing flibanserin polymorph A |
| 08/17/2005 | CN1655782A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 08/17/2005 | CN1655772A Plaster containing fentanyl |
| 08/17/2005 | CN1655771A At least partially degradable films containing an active ingredient and method for the production thereof |
| 08/17/2005 | CN1655770A Chewable soft capsule |
| 08/17/2005 | CN1655769A Polysaccharide capsules and methods of preparation |